Healthcare -
Biotechnology - NASDAQ - US
$ 0.0836
10.8 %
$ 1.44 M
Market Cap
-0.01
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
NRx Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 19.7 M |
| Operating Income | -18.5 M |
| Other Expenses | 6.62 M |
| Net Income | -25.1 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 0 | 5 K | 4 K | 2 K | 0.9 | 0 | 1.0 | 0 |
| Gross Profit | 0 | 5 K | 4 K | 2 K | (0.9) | 0 | (1.0) | 0 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 19.7 | 27.6 | 44.4 | 94.4 | 11.9 | 6.43 K | 1.0 | 0 |
| Selling, General and Administrative Expenses | 13.5 | 14.2 | 27.4 | 74.9 | 11.4 | 2.77 K | 1.0 | 0 |
| Research and Development Expenses | 6.2 | 13.4 | 17.0 | 20.3 | 10.6 | 3.5 K | 0 | 0 |
| Operating Income | (18.5) | (27.6) | (44.4) | (115.8) | (51.4) | 6.26 K | (1.0) | 0 |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0.2 | 0.1 | 0 | 18 K | 56 K | 0 | 0 | 0 |
| Total Other Income | (6.6) | (2.6) | 4.6 | 22.7 | (39.9) | 1.2 | 1.1 | (0.1) |
| Pre-Tax Income | (25.1) | (30.2) | (39.8) | (93.1) | (51.8) | 0.5 | 82.4 K | (0.1) |
| NET INCOME | ||||||||
| Tax Provision | 0 | 9 K | (4.6) | (21.3) | (39.4) | 84.2 K | 16.3 K | 0 |
| Net Income | (25.1) | (30.1) | (35.2) | (71.7) | (12.3) | 0.4 | 66.1 K | (0.1) |
| EPS | 2.39 | 3.98 | 0.54 | 1.53 | 0.36 | 0.8 | 0.0741 | 0.12 |